Logo image of LIEN

CHICAGO ATLANTIC BDC INC (LIEN) Stock Fundamental Analysis

NASDAQ:LIEN - Nasdaq - US8281741020 - Common Stock - Currency: USD

10.31  -0.09 (-0.87%)

Fundamental Rating

5

Overall LIEN gets a fundamental rating of 5 out of 10. We evaluated LIEN against 235 industry peers in the Capital Markets industry. LIEN is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. LIEN has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

LIEN had positive earnings in the past year.
LIEN had a negative operating cash flow in the past year.
LIEN Yearly Net Income VS EBIT VS OCF VS FCFLIEN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 5M -5M 10M

1.2 Ratios

The Return On Assets of LIEN (5.33%) is better than 73.19% of its industry peers.
LIEN's Return On Equity of 5.55% is in line compared to the rest of the industry. LIEN outperforms 40.85% of its industry peers.
LIEN's Return On Invested Capital of 5.35% is fine compared to the rest of the industry. LIEN outperforms 64.68% of its industry peers.
Industry RankSector Rank
ROA 5.33%
ROE 5.55%
ROIC 5.35%
ROA(3y)3.58%
ROA(5y)N/A
ROE(3y)3.7%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LIEN Yearly ROA, ROE, ROICLIEN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 50 -50

1.3 Margins

Looking at the Profit Margin, with a value of 54.23%, LIEN belongs to the top of the industry, outperforming 94.47% of the companies in the same industry.
LIEN's Operating Margin of 66.22% is amongst the best of the industry. LIEN outperforms 98.72% of its industry peers.
Looking at the Gross Margin, with a value of 77.36%, LIEN belongs to the top of the industry, outperforming 82.98% of the companies in the same industry.
Industry RankSector Rank
OM 66.22%
PM (TTM) 54.23%
GM 77.36%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
LIEN Yearly Profit, Operating, Gross MarginsLIEN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 -1K -2K -3K -4K -5K

7

2. Health

2.1 Basic Checks

The number of shares outstanding for LIEN has been increased compared to 1 year ago.
LIEN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
LIEN Yearly Shares OutstandingLIEN Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 5M 10M 15M 20M
LIEN Yearly Total Debt VS Total AssetsLIEN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

LIEN has an Altman-Z score of 11.58. This indicates that LIEN is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of LIEN (11.58) is better than 92.77% of its industry peers.
There is no outstanding debt for LIEN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 11.58
ROIC/WACCN/A
WACCN/A
LIEN Yearly LT Debt VS Equity VS FCFLIEN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

A Current Ratio of 1.96 indicates that LIEN should not have too much problems paying its short term obligations.
LIEN's Current ratio of 1.96 is fine compared to the rest of the industry. LIEN outperforms 67.66% of its industry peers.
A Quick Ratio of 1.96 indicates that LIEN should not have too much problems paying its short term obligations.
The Quick ratio of LIEN (1.96) is better than 68.09% of its industry peers.
Industry RankSector Rank
Current Ratio 1.96
Quick Ratio 1.96
LIEN Yearly Current Assets VS Current LiabilitesLIEN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 20M 40M 60M 80M

4

3. Growth

3.1 Past

The earnings per share for LIEN have decreased by -1.65% in the last year.
Looking at the last year, LIEN shows a very strong growth in Revenue. The Revenue has grown by 152.04%.
EPS 1Y (TTM)-1.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%3.03%
Revenue 1Y (TTM)152.04%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%331.95%

3.2 Future

Based on estimates for the next years, LIEN will show a very strong growth in Earnings Per Share. The EPS will grow by 41.75% on average per year.
The Revenue is expected to grow by 78.59% on average over the next years. This is a very strong growth
EPS Next Y90.53%
EPS Next 2Y41.75%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year170.99%
Revenue Next 2Y78.59%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

LIEN Yearly Revenue VS EstimatesLIEN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 20M 40M 60M
LIEN Yearly EPS VS EstimatesLIEN Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 0 0.5 1 1.5

6

4. Valuation

4.1 Price/Earnings Ratio

LIEN is valuated reasonably with a Price/Earnings ratio of 11.85.
Based on the Price/Earnings ratio, LIEN is valued a bit cheaper than the industry average as 65.11% of the companies are valued more expensively.
LIEN is valuated cheaply when we compare the Price/Earnings ratio to 27.35, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 6.62, the valuation of LIEN can be described as very cheap.
Based on the Price/Forward Earnings ratio, LIEN is valued cheaper than 94.47% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 37.54. LIEN is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 11.85
Fwd PE 6.62
LIEN Price Earnings VS Forward Price EarningsLIEN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LIEN Per share dataLIEN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

LIEN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
LIEN's earnings are expected to grow with 41.75% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.13
PEG (5Y)N/A
EPS Next 2Y41.75%
EPS Next 3YN/A

4

5. Dividend

5.1 Amount

LIEN has a Yearly Dividend Yield of 12.14%, which is a nice return.
Compared to an average industry Dividend Yield of 8.05, LIEN pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.36, LIEN pays a better dividend.
Industry RankSector Rank
Dividend Yield 12.14%

5.2 History

LIEN has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
LIEN Yearly Dividends per shareLIEN Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

LIEN pays out 65.00% of its income as dividend. This is not a sustainable payout ratio.
DP65%
EPS Next 2Y41.75%
EPS Next 3YN/A
LIEN Yearly Income VS Free CF VS DividendLIEN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2021 2022 2023 2024 0 5M -5M 10M
LIEN Dividend Payout.LIEN Dividend Payout, showing the Payout Ratio.LIEN Dividend Payout.PayoutRetained Earnings

CHICAGO ATLANTIC BDC INC

NASDAQ:LIEN (7/24/2025, 8:00:02 PM)

10.31

-0.09 (-0.87%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)05-14 2025-05-14/bmo
Earnings (Next)08-06 2025-08-06/amc
Inst Owners20.27%
Inst Owner ChangeN/A
Ins Owners0.33%
Ins Owner Change0.06%
Market Cap235.27M
Analysts43.33
Price Target12.38 (20.08%)
Short Float %0.17%
Short Ratio0.82
Dividend
Industry RankSector Rank
Dividend Yield 12.14%
Yearly Dividend0.86
Dividend Growth(5Y)N/A
DP65%
Div Incr Years0
Div Non Decr Years0
Ex-Date06-27 2025-06-27 (0.34)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)12.93%
Min EPS beat(2)7.53%
Max EPS beat(2)18.32%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)6.83%
Min Revenue beat(2)0.94%
Max Revenue beat(2)12.73%
Revenue beat(4)4
Avg Revenue beat(4)28.82%
Min Revenue beat(4)0.94%
Max Revenue beat(4)53.37%
Revenue beat(8)8
Avg Revenue beat(8)18.11%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-8.58%
EPS NQ rev (1m)0%
EPS NQ rev (3m)27.86%
EPS NY rev (1m)0%
EPS NY rev (3m)30.45%
Revenue NQ rev (1m)-0.13%
Revenue NQ rev (3m)22.27%
Revenue NY rev (1m)0.78%
Revenue NY rev (3m)26.67%
Valuation
Industry RankSector Rank
PE 11.85
Fwd PE 6.62
P/S 7.63
P/FCF N/A
P/OCF N/A
P/B 0.78
P/tB 0.78
EV/EBITDA N/A
EPS(TTM)0.87
EY8.44%
EPS(NY)1.56
Fwd EY15.11%
FCF(TTM)-0.63
FCFYN/A
OCF(TTM)-0.63
OCFYN/A
SpS1.35
BVpS13.19
TBVpS13.19
PEG (NY)0.13
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.33%
ROE 5.55%
ROCE 6.78%
ROIC 5.35%
ROICexc 5.63%
ROICexgc 5.63%
OM 66.22%
PM (TTM) 54.23%
GM 77.36%
FCFM N/A
ROA(3y)3.58%
ROA(5y)N/A
ROE(3y)3.7%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.1
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.96
Quick Ratio 1.96
Altman-Z 11.58
F-Score2
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%3.03%
EPS Next Y90.53%
EPS Next 2Y41.75%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)152.04%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%331.95%
Revenue Next Year170.99%
Revenue Next 2Y78.59%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y155.31%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-187.57%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-187.57%
OCF growth 3YN/A
OCF growth 5YN/A